EP1535910A4 — QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITORS OF THE FACTOR RECEPTOR AUTOPHOSPHORYLATION STIMULATING THE PROLIFERATION OF MACROPHAGES
Assigned to Kirin Pharma KK · Expires 2007-03-14 · 19y expired
What this patent protects
It is intended to provide compounds inhibiting the autophosphorylation of macrophage colony stimulating factor receptor. Thus, compounds of the following general formula (I), salts thereof and solvates of the same are provided. (I) wherein X represents CH or N; Z represents O or …
USPTO Abstract
It is intended to provide compounds inhibiting the autophosphorylation of macrophage colony stimulating factor receptor. Thus, compounds of the following general formula (I), salts thereof and solvates of the same are provided. (I) wherein X represents CH or N; Z represents O or S; R1, R2 and R3 represent each H, optionally substituted alkoxy, etc.; R4 represents H; R5, R6, R7 and R8 represent each H, halogeno, alkyl, alkoxy, trifluoromethyl, etc.; R9 and R10 represent each H, alkyl, etc.; and one of R11 and R12 represents H while the other represents alkyl and R13 represents an optionally substituted carbon ring, a heterocycle, etc., or R11 represents H and R12 and R13 together form a bicyclic carbon ring.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.